In vivo, these SLNs significantly ameliorated cognitive deficits, reduced neuroinflammation and Aβ/tau pathology, and preserved hippocampal architecture in a sporadic AD mouse model [56]. This evidence concerns the gene MAPT and Alzheimer disease.